Active broad-market exchange-traded funds in Thursday's regular
SPDR S&P 500 ETF Trust (
): -0.6%, with new 52-week highs
iShares MSCI Emerging Markets Index (
iShares Russell 2000 Index (
): -0.9%, with new 52-week highs
PowerShares QQQ Trust, Series 1 (
): -1.2% from near 52-week highs
iPath S&P 500 VIX Short Term Futures TM (
): now +1.1%, earlier hit a new 52-week low
Broad Market Indicators
Many broad-market exchange-traded funds, including SPY, IWM, IVV
and others were now in the red, but lots of them reached or got
near 52-week highs earlier. Reflecting this, actively traded
PowerShares QQQ (
) was down 1.2% from near 52-week highs.
U.S. stocks were also in negative territory, as earlier
enthusiasm on the heels of a surprise rate cut by the European
Central Bank, added to unexpectedly strong domestic economic data
fizzled. Weekly jobless claims fell by 9,000 to 336,000, exceeding
economists' forecasts. Meanwhile, U.S. GDP rose 2.8% in Q3.
) much-hyped IPO supported stocks, but the sentiment stemming from
that was not enought to help sustain positive momentum.
Power Play: Technology
Technology Select Sector SPDR ETF (XLK), iShares Dow Jones US
Technology ETF (IYW), iShares S&P North American Technology ETF
(IGM), and iShares S&P North American Technology-Software Index
(IGV) were all weaker, but all earlier reached 52-week highs.
Among semiconductor ETFs, SPDR S&P Semiconductor (XSD) was
down 1% and Semiconductor Sector Index Fund (SOXX) was down 1.1%.
SPDR S&P International Technology Sector ETF (IPK) off 0.6%,
but near 52-week highs.
Among stocks, Twitter Inc (TWTR) opened at $45.10 - a 73% bulge
over its $26 IPO price - and was over 77% higher at last look,
although off a high of $50.09. This, still, gave the micro-blogging
website a market value of near $25 billion in its debut on the New
York Stock Exchange today.
Winners and Losers
Select Financial Sector SPDRs (XLF) has turned negative and is
now down 0.2%, but still near its 52-week high. Direxion Daily
Financial Bull 3X shares (FAS) was down 1.1%. Its bearish
counterpart, FAZ, was up 1.1% after sinking to a new 52-week
Among financial stocks, St. Joe Company (JOE) was up near 20%
after the company said it has agreed to sell 382,834 acres of its
non-strategic timberland and rural land in Northwest Florida for
$565 million to Utah-based AgReserves.
Dow Jones U.S. Energy Fund (IYE) was down 0.45% and Energy
Select Sector SPDR (XLE) was down 0.6% - with both reaching new
52-week highs earlier.
In sector news, Apache (APA) was up 2% and neared a 52-week high
after reporting Q3 EPS of $2.32 on revenues of $4.41 billion, which
topped the Capital IQ consensus estimate as production grew
sequentially by 13,000 barrels per day of oil and natural gas
Crude was down 0.51%; United States Oil Fund (USO) was down
0.7%. Meanwhile, natural gas was up 0.84%, and United States
Natural Gas Fund (UNG) was up 0.5%.
Gold was down 0.68%, and SPDR Gold Trust (GLD) was down 0.75%.
Silver was down 0.43%; iShares Silver Trust (SLV) was down
Health Care SPDR (XLV) was down 0.25%, but reached a new 52-week
high; likewise, Vanguard Health Care ETF (VHT) and iShares Dow
Jones US Healthcare (IYH) were weaker, but with fresh new 52-week
highs. Biotech ETF iShares NASDAQ Biotechnology Index (IBB) was
Among stocks, Geron Corp (GERN) has soared more than 60% but is
nearly $2 off a new 52-week high hit earlier following the release
of a supportive Mayo Clinic study of GERN's imetelstat drug
candidate in treating myelofibrosis. According to The Street.com,
which obtained a copy of the study results, four patients had
complete remission and another patient had a partial remission.
Three other patients also showed clinical improvement out of a
total 18 patients evaluable for response - 11 from the first Cohort
A and 7 from Cohort B.
Consumer Staples Select Sector SPDR (XLP) was down 0.86%,
reaching a new 52-week high of $42.71; Vanguard Consumer Staples
ETF (VDC) and iShares Dow Jones US Consumer Goods (IYK) edged
lower, also with new 52-week highs.
Among stocks, Tempur Sealy (TPX) was up 16% after reporting Q3
EPS of $0.73, on sales of $735.5 million, versus the Capital IQ
analyst consensus of $0.68 per share on sales of $708 million. For
the full year 2013, the company expects sales of $2.425 billion -
$2.45 billion and EPS of $2.25 - $2.40, versus the Street view of
$2.43 billion in sales and earnings of $2.31 per share.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.